Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darrell M Wilson

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Contemporary Clinical Trials|September 14, 2013
Family, community and clinic collaboration to treat overweight and obese children: Stanford GOALS-A randomized controlled trial of a three-year, multi-component, multi-level, multi-setting interventionThomas N Robinson, Donna Matheson, Manisha Desai, et al.
Diabetologia|February 11, 2025
Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes developmentPeter Calhoun, Charles Spanbauer, Andrea K Steck, et al.
Diabetes Technology & Therapeutics|November 15, 2021
Predicting Success with a First-Generation Hybrid Closed-Loop Artificial Pancreas System Among Children, Adolescents, and Young Adults with Type 1 Diabetes: A Model Development and Validation StudyGregory P Forlenza, Tim Vigers, Cari Berget, et al.
Diabetologia|November 27, 2019
The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screeningLaura M Jacobsen, Laura Bocchino, Carmella Evans-Molina, et al.
Diabetes Care|September 2, 2017
Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention TrialsBrandon M Nathan, David Boulware, Susan Geyer, et al.
Contemporary Clinical Trials|June 30, 2007
Stanford GEMS phase 2 obesity prevention trial for low-income African-American girls: design and sample baseline characteristicsThomas N Robinson, Helena C Kraemer, Donna M Matheson, et al.
The Lancet. Diabetes & Endocrinology|May 2, 2021
A community-based, multi-level, multi-setting, multi-component intervention to reduce weight gain among low socioeconomic status Latinx children with overweight or obesity: The Stanford GOALS randomised controlled trialThomas N Robinson, Donna Matheson, Darrell M Wilson, et al.
Diabetes Care|May 9, 2014
A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetesDavid M Maahs, Peter Calhoun, Bruce A Buckingham, et al.
Obesity (Silver Spring, Md.)|May 29, 2013
A cross-sectional study of osteocalcin and body fat measures among obese adolescentsCarine M Lenders, Phillip D K Lee, Henry A Feldman, et al.
Diabetes|October 30, 2015
Variations in Brain Volume and Growth in Young Children With Type 1 DiabetesPaul K Mazaika, Stuart A Weinzimer, Nelly Mauras, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Contemporary Clinical Trials|September 14, 2013
Family, community and clinic collaboration to treat overweight and obese children: Stanford GOALS-A randomized controlled trial of a three-year, multi-component, multi-level, multi-setting interventionThomas N Robinson, Donna Matheson, Manisha Desai, et al.
Diabetologia|February 11, 2025
Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes developmentPeter Calhoun, Charles Spanbauer, Andrea K Steck, et al.
Diabetes Technology & Therapeutics|November 15, 2021
Predicting Success with a First-Generation Hybrid Closed-Loop Artificial Pancreas System Among Children, Adolescents, and Young Adults with Type 1 Diabetes: A Model Development and Validation StudyGregory P Forlenza, Tim Vigers, Cari Berget, et al.
Diabetologia|November 27, 2019
The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screeningLaura M Jacobsen, Laura Bocchino, Carmella Evans-Molina, et al.
Diabetes Care|September 2, 2017
Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention TrialsBrandon M Nathan, David Boulware, Susan Geyer, et al.
Contemporary Clinical Trials|June 30, 2007
Stanford GEMS phase 2 obesity prevention trial for low-income African-American girls: design and sample baseline characteristicsThomas N Robinson, Helena C Kraemer, Donna M Matheson, et al.
The Lancet. Diabetes & Endocrinology|May 2, 2021
A community-based, multi-level, multi-setting, multi-component intervention to reduce weight gain among low socioeconomic status Latinx children with overweight or obesity: The Stanford GOALS randomised controlled trialThomas N Robinson, Donna Matheson, Darrell M Wilson, et al.
Diabetes Care|May 9, 2014
A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetesDavid M Maahs, Peter Calhoun, Bruce A Buckingham, et al.
Obesity (Silver Spring, Md.)|May 29, 2013
A cross-sectional study of osteocalcin and body fat measures among obese adolescentsCarine M Lenders, Phillip D K Lee, Henry A Feldman, et al.
Diabetes|October 30, 2015
Variations in Brain Volume and Growth in Young Children With Type 1 DiabetesPaul K Mazaika, Stuart A Weinzimer, Nelly Mauras, et al.
Pageof 11